Skip to main content

Advertisement

Log in

Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results

  • Clinical Article - Vascular
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Background

Severe cerebral vasospasm is a major cause of death and disability in patients with aneurysmal subarachnoid hemorrhage. No causative treatment is yet available and hypertensive hypervolemic therapy (HHT) is often insufficient to avoid delayed cerebral ischemia and neurological deficits. We compared patients receiving continuous intra-arterial infusion of the calcium-antagonist nimodipine with a historical group treated with HHT and oral nimodipine alone.

Methods

Between 0.5 and 1.2 mg/h of nimodipine were continuously administered by intra-arterial infusion via microcatheters either into the internal carotid or vertebral artery or both, depending on the areas of vasospasm. The effect was controlled via multimodal neuromonitoring and transcranial Doppler sonography. Outcome was determined by means of the Glasgow Outcome Scale at discharge and 6 months after the hemorrhage and compared to a historical control group.

Results

Twenty-one patients received 28 intra-arterial nimodipine infusions. Six months after discharge, the occurrence of cerebral infarctions was significantly lower (42.6 %) in the nimodipine group than in the control group (75.0 %). This result was reflected by a significantly higher proportion (76.0 %) of patients with good outcome in the nimodipine-treated group, when compared to 10.0 % good outcome in the control group. Median GOS was 4 in the nimodipine group and 2 in the control group (p = 0.001).

Conclusions

Continuous intra-arterial nimodipine infusion is an effective treatment for patients with severe cerebral vasospasm who fail to respond to HHT and oral nimodipine alone. Key to the effective administration of continuous intra-arterial nimodipine is multimodal neuromonitoring and the individual adaptation of dosage and time of infusion for each patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Agrawal A, Patir R, Kato Y, Chopra S, Sano H, Kanno T (2009) Role of intraventricular sodium nitroprusside in vasospasm secondary to aneurysmal subarachnoid haemorrhage: a 5-year prospective study with review of the literature. Minim Invasive Neurosurg: MIN 52:5–8

    Article  CAS  PubMed  Google Scholar 

  2. Biondi A, Le Jean L, Puybasset L (2006) Clinical experience of selective intra-arterial nimodipine treatment for cerebral vasospasm following subarachnoid hemorrhage. AJNR Am J Neuroradiol 27:474, author reply 474

    PubMed  Google Scholar 

  3. Biondi A, Ricciardi GK, Puybasset L, Abdennour L, Longo M, Chiras J, Van Effenterre R (2004) Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol 25:1067–1076

    PubMed  Google Scholar 

  4. Crowley RW, Medel R, Kassell NF, Dumont AS (2008) New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage. Drug Discov Today 13:254–260

    Article  CAS  PubMed  Google Scholar 

  5. Dabus G, Nogueira RG (2013) Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature. Interv Neurol 2:30–51

    Article  PubMed Central  PubMed  Google Scholar 

  6. Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, Hanggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G, Neurocritical Care S (2011) Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care 15:211–240

    Article  PubMed  Google Scholar 

  7. Gandolfo C (1986) Subarachnoid hemorrhage. Epidemiological data. Minerva Med 77:1041–1044

    CAS  PubMed  Google Scholar 

  8. Grotenhuis JA, Bettag W, Fiebach BJ, Dabir K (1984) Intracarotid slow bolus injection of nimodipine during angiography for treatment of cerebral vasospasm after SAH. A preliminary report. J Neurosurg 61:231–240

    Article  CAS  PubMed  Google Scholar 

  9. Hui C, Lau KP (2005) Efficacy of intra-arterial nimodipine in the treatment of cerebral vasospasm complicating subarachnoid haemorrhage. Clin Radiol 60:1030–1036

    Article  CAS  PubMed  Google Scholar 

  10. Jestaedt L, Pham M, Bartsch AJ, Kunze E, Roosen K, Solymosi L, Bendszus M (2008) The impact of balloon angioplasty on the evolution of vasospasm-related infarction after aneurysmal subarachnoid hemorrhage. Neurosurgery 62:610–617, discussion 610–617

    Article  PubMed  Google Scholar 

  11. Karinen P, Koivukangas P, Ohinmaa A, Koivukangas J, Ohman J (1999) Cost-effectiveness analysis of nimodipine treatment after aneurysmal subarachnoid hemorrhage and surgery. Neurosurgery 45:780–784, discussion 784–785

    Article  CAS  PubMed  Google Scholar 

  12. Liu JK, Tenner MS, Gottfried ON, Stevens EA, Rosenow JM, Madan N, MacDonald JD, Kestle JR, Couldwell WT (2004) Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. J Neurosurg 100:414–421

    Article  CAS  PubMed  Google Scholar 

  13. Mayer TE, Dichgans M, Straube A, Birnbaum T, Muller-Schunk S, Hamann GF, Schulte-Altedorneburg G (2008) Continuous intra-arterial nimodipine for the treatment of cerebral vasospasm. Cardiovasc Intervent Radiol 31:1200–1204

    Article  PubMed  Google Scholar 

  14. Meyer FB (1990) Calcium antagonists and vasospasm. Neurosurg Clin N Am 1:367–376

    CAS  PubMed  Google Scholar 

  15. Musahl C, Henkes H, Vajda Z, Coburger J, Hopf N (2011) Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage. Neurosurgery 68:1541–1547, discussion 1547

    Article  PubMed  Google Scholar 

  16. Numaguchi Y, Zoarski GH, Clouston JE, Zagardo MT, Simard JM, Aldrich EF, Sloan MA, Maurer PK, Okawara SH (1997) Repeat intra-arterial papaverine for recurrent cerebral vasospasm after subarachnoid haemorrhage. Neuroradiology 39:751–759

    Article  CAS  PubMed  Google Scholar 

  17. Ott S, Jedlicka S, Wolf S, Peter M, Pudenz C, Merker P, Schurer L, Lumenta CB (2014) Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage. BioMed Res Int 2014:970741

    Article  PubMed Central  PubMed  Google Scholar 

  18. Pachl J, Haninec P, Tencer T, Mizner P, Houst’ava L, Tomas R, Waldauf P (2005) The effect of subarachnoid sodium nitroprusside on the prevention of vasospasm in subarachnoid haemorrhage. Acta Neurochir Suppl (Wien) 95:141–145

    Article  CAS  Google Scholar 

  19. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298:636–642

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Qureshi AI, Luft AR, Sharma M, Guterman LR, Hopkins LN (2000) Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part II--Clinical aspects and recommendations. Neurosurgery 46:1360–1375, discussion 1375–1376

    Article  CAS  PubMed  Google Scholar 

  21. Raabe A, Zimmermann M, Setzer M, Vatter H, Berkefeld J, Seifert V (2002) Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm. Neurosurgery 50:1006–1013, discussion 1013–1014

    PubMed  Google Scholar 

  22. Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J (2005) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (1):CD000277. doi:10.1002/14651858.CD000277.pub2

  23. Rosenwasser RH, Armonda RA, Thomas JE, Benitez RP, Gannon PM, Harrop J (1999) Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 44:975–979, discussion 979–980

    Article  CAS  PubMed  Google Scholar 

  24. Weir B, MacDonald L (1993) Cerebral vasospasm. Clin Neurosurg 40:40–55

    CAS  PubMed  Google Scholar 

  25. Wolf S, Martin H, Landscheidt JF, Rodiek SO, Schurer L, Lumenta CB (2010) Continuous selective intraarterial infusion of nimodipine for therapy of refractory cerebral vasospasm. Neurocrit Care 12:346–351

    Article  CAS  PubMed  Google Scholar 

  26. Wu CT, Wong CS, Yeh CC, Borel CO (2004) Treatment of cerebral vasospasm after subarachnoid hemorrhage—a review. Acta Anaesthesiol Taiwan 42:215–222

    PubMed  Google Scholar 

  27. Zhang YP, Shields LB, Yao TL, Dashti SR, Shields CB (2013) Intrathecal treatment of cerebral vasospasm. J Stroke Cerebrovasc Dis 22:1201–1211

    Article  PubMed  Google Scholar 

  28. Zubkov YN, Nikiforov BM, Shustin VA (1984) Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir (Wien) 70:65–79

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sylvia Bele.

Ethics declarations

Conflict of interest

The author(s) declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bele, S., Proescholdt, M.A., Hochreiter, A. et al. Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results. Acta Neurochir 157, 2041–2050 (2015). https://doi.org/10.1007/s00701-015-2597-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-015-2597-z

Keywords

Navigation